Canada markets closed

Ampio Pharmaceuticals, Inc. (APH.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1702+0.0074 (+4.55%)
At close: 08:01AM CEST

Ampio Pharmaceuticals, Inc.

373 Inverness Parkway
Suite 200
Englewood, CO 80112
United States
720 437 6500
https://www.ampiopharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees20

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael A. MartinoCEO & Chairman585.71kN/A1957
Ms. Holli CherevkaPres & COO306.59kN/A1983
Mr. Daniel G. Stokely CPA, CPACFO, Corp. Sec. & Treasurer301.36kN/A1964
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D.Chief Medical OfficerN/AN/A1954
Lane HapkeVP of Manufacturing OperationsN/AN/AN/A
April RamirezClinical Trial Mang.N/AN/AN/A
Laura GoldbergVP of Quality and Regulatory OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Corporate Governance

Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 9. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 4; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.